The first use of the Genesis robotic magnetic navigation (RMN) system comes as part of a robotic heart program at the health system. Genesis delivers the benefits of robotic precision and safety to cardiac ablation to treat arrhythmias.
“For years, advanced robot technology has been instrumental in our ability to deliver superior care to our patients, allowing us to navigate complex cardiac procedures with improved accuracy and safety,” said Dr. Seth Sheldon, Cardiac Electrophysiologist at the health system. “The robotic precision and stability offered by the Genesis System allows us to deliver precise, personalized treatments to our patients, ultimately improving outcomes and quality of life.”
Genesis utilizes smaller magnets that rotate along their center of mass, allowing for responsiveness to physician control. The smaller system can improve the patient experience, provide greater patient access and increase lab space. Flexible, rugged robotic arms hold the agents to increase the potential range of motion and allow for wider X-ray angulation.
A hospital in Kentucky performed the first procedures with the Genesis surgical robotic system late last year. Stereotaxis also has an ongoing surgical robotics collaboration with Abbott, which had milestone developments last fall. The company features on MassDevice’s 2024 list of 10 surgical robotics companies you need to know.
“We are proud to continue our partnership with the health system to deliver exceptional cardiac care to patients in Kansas City,” said David Fischel, Chairman and CEO of Stereotaxis. “We look forward to continuing to support their successful and impactful robotic heart rhythm care program.”
In August, Stereotaxis submitted its next-generation GenesisX system to the FDA following receipt of CE mark.
